Guenter Fingerle-Rowson
About
In The Last Decade
Guenter Fingerle-Rowson
28 papers receiving 534 citations
Peers
Comparison fields: 5 of 42
- Pathology and Forensic Medicine 455
- Genetics 394
- Immunology 204
- Oncology 137
- Neurology 87
Countries citing papers authored by Guenter Fingerle-Rowson
This map shows the geographic impact of Guenter Fingerle-Rowson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guenter Fingerle-Rowson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guenter Fingerle-Rowson more than expected).
Fields of papers citing papers by Guenter Fingerle-Rowson
This network shows the impact of papers produced by Guenter Fingerle-Rowson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guenter Fingerle-Rowson. The network helps show where Guenter Fingerle-Rowson may publish in the future.
Co-authorship network of co-authors of Guenter Fingerle-Rowson
This figure shows the co-authorship network connecting the top 25 collaborators of Guenter Fingerle-Rowson. A scholar is included among the top collaborators of Guenter Fingerle-Rowson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guenter Fingerle-Rowson. Guenter Fingerle-Rowson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 20 | |
| 4 | 75 | |
| 5 | Immunochemotherapy With Obinutuzumab Or Rituximab In Previously Untreated Follicular Lymphoma In The Randomized Phase III Gallium Study: Analysis By Chemotherapy Regimen | 1 |
| 6 | Comparison Of Contrast-Enhanced Ct-Based Response With Pet Assessment After First-Line Therapy For Follicular Lymphoma In The Phase Iii Gallium Study | 1 |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 6 | |
| 11 | 8 | |
| 12 | 7 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 5 | |
| 16 | 10 | |
| 17 | 73 | |
| 18 | 5 | |
| 19 | 1 | |
| 20 | 201 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.